2021
DOI: 10.1007/s00068-020-01586-9
|View full text |Cite
|
Sign up to set email alerts
|

Low profile REBOA device for increasing systolic blood pressure in hemodynamic instability: single-center 4-year experience of use of ER-REBOA

Abstract: Background Hemodynamic instability due to torso hemorrhage can be managed with the assistance of resuscitative endovascular balloon occlusion of the aorta (REBOA). This is a report of a single-center experience using the ER-REBOA™ catheter for traumatic and non-traumatic cases as an adjunct to hemorrhage control and as part of the EndoVascular resuscitation and Trauma Management (EVTM) concept. The objective of this report is to describe the clinical usage, technical success, results, complicatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 23 publications
(28 reference statements)
0
5
0
Order By: Relevance
“… 49 The compliance of first-generation catheter balloons, like the Eliason-Rasmussen REBOA (ER-REBOA), limits control during deflation, leading to an all-or-nothing approach. 16 35 Challenges also arise from difficulty in predicting optimal balloon volume for transition from complete to partial occlusion and the unpredictable interaction of fully compliant balloons with the aortic wall. 48 50 51 …”
Section: Resultsmentioning
confidence: 99%
“… 49 The compliance of first-generation catheter balloons, like the Eliason-Rasmussen REBOA (ER-REBOA), limits control during deflation, leading to an all-or-nothing approach. 16 35 Challenges also arise from difficulty in predicting optimal balloon volume for transition from complete to partial occlusion and the unpredictable interaction of fully compliant balloons with the aortic wall. 48 50 51 …”
Section: Resultsmentioning
confidence: 99%
“…While its use has been described in trauma and vascular surgery, it also has a major role in non-traumatic bleeding and resuscitation as part of the EVTM concept [6], with indications and contraindications for its use continuing to evolve. Existing evidence from case reports, animal and cohort studies suggest its use in both blunt or penetrating trauma; gastrointestinal (GI), obstetric-and gynaecologyderived bleeding events; visceral aneurysm rupture; thoracic and abdominal aortic aneurysm rupture; post-abdominal surgery; iatrogenic injuries; and, potentially, in both traumatic and non-traumatic cardiac arrest [6,9]. The lack of level 1 evidence such as randomized controlled trials, however, prevent consensus.…”
Section: Reboa Technique Indications and Contraindicationsmentioning
confidence: 99%
“…The suggested use of REBOA has been mainly in-hospital [5,6,12]; however, pre-hospital use has been reported in around 60 known cases in military and selected civilian reports [13] as well as in some unpublished data. The prehospital use of zone I (descending thoracic aorta) occlusion with REBOA has previously been controversial, especially in the case of thoracic trauma.…”
Section: Reboa Technique Indications and Contraindicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is gaining increasing popularity for use in obtaining temporary proximal hemorrhage control and temporary hemodynamic stability, whilst maintaining cerebral and myocardial perfusion (1)(2)(3)(4). According to the concept of EndoVascular resuscitation and Trauma Management (EVTM), the suggested use of REBOA has been mainly in-hospital (5)(6)(7)(8); however, pre-hospital use has been reported in around 60 known cases in military and selected civilian reports (9)(10)(11). The pre-hospital use of zone 1 (descending thoracic aorta) occlusion with REBOA (2) has previously been controversial, especially in the case of thoracic trauma (12).…”
Section: Introductionmentioning
confidence: 99%